RAP 0.00% 20.5¢ resapp health limited

Ann: Medgate commences European ResAppDx trial, page-37

  1. 170 Posts.
    lightbulb Created with Sketch. 56
    It beggars belief when you think about the level of positivity expressed in many historical announcements and quarterlies.

    Big lesson for me. Don’t buy the hype of rookie management. They are frothing on their inexperienced expectations and overhyping the probability of success = NOT a balanced overview of the reasonably expected potential of the company.

    Time for new leadership talent please. TK you are nice, great and smart. You are a scientist.

    Please WHATS THE PLAN TK?

    Do we have a spreadsheet detailing the business development strategy from a share price of 5.8c I’m mean for crying out loud is COVID the problem?

 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.